On Friday, Organovo Holdings Inc (ONVO) stock saw a modest uptick, ending the day at $0.44 which represents no change from the prior close of of $0.44. The stock opened at $0.46 and touched a low of ...

Organovo Holdings ( (ONVO)) just unveiled an update. At its 2024 Annual Meeting, Organovo Holdings, Inc. secured stockholder approval for several key proposals, including an amendment to its 2022 ...

The presentation entitled “Pharmacokinetics, Safety and Efficacy of the Novel Non-bile Acid FXR Agonist FXR314 in Patients with Metabolic Dysfunction-Associated Steatohepatitis: Results from a Phase 2 ...

Organovo Holdings (NASDAQ:ONVO), Inc., a biotechnology firm specializing in biological products, has announced an expansion of its equity incentive plan, following approval from its stockholders.

Organovo Holdings (NASDAQ:ONVO), Inc., a biotechnology firm specializing in biological products, has announced an expansion of its equity incentive plan, following approval from its stockholders.

Organovo (ONVO) announces that its oral presentation of its lead clinical stage drug FXR314 by Dr. Eric Lawitz of the Texas Liver Institute and the University of Texas Health San Antonio was ...

SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...

SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotechnology company specializing in novel treatments for inflammatory bowel disease and other conditions, announced significant findings from ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Friday reported a loss of $2.5 million in its fiscal second quarter. The San Diego-based company said it had a loss of 14 ...

Shares of ONVO stock opened at $0.38 on Tuesday. Organovo has a fifty-two week low of $0.32 and a fifty-two week high of $1.74. The firm has a market cap of $5.84 million, a P/E ratio of -0.36 and ...